Balyasny Asset Management LLC Bausch Health Companies Inc. Transaction History

Balyasny Asset Management LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$6.1 - $10.41 $1.07 Million - $1.82 Million	174,891 Added 101.31%	347,517 $2.42 Million
Q1 2024 May 13, 2024	BUY	$7.77 - $10.61 $1.34 Million - $1.83 Million	172,626 New	172,626 $1.83 Million
Q2 2023 Aug 14, 2023	BUY	$5.72 - $8.8 $3.3 Million - $5.08 Million	577,680 New	577,680 $4.62 Million
Q4 2022 Feb 14, 2023	SELL	$6.09 - $7.93 $847,910 - $1.1 Million	-139,230 Reduced 23.24%	459,786 $2.89 Million
Q3 2022 Nov 14, 2022	BUY	$4.58 - $9.21 $2.74 Million - $5.52 Million	599,016 New	599,016 $4.13 Million
Q1 2022 May 16, 2022	SELL	$21.6 - $27.79 $5.05 Million - $6.5 Million	-233,826 Reduced 70.04%	100,000 $2.29 Million
Q4 2021 Feb 14, 2022	BUY	$23.0 - $29.01 $7.68 Million - $9.68 Million	333,826 New	333,826 $9.22 Million
Q3 2021 Nov 15, 2021	SELL	$25.04 - $30.06 $3.77 Million - $4.53 Million	-150,635 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$27.43 - $32.7 $19.2 Million - $22.8 Million	-698,507 Reduced 82.26%	150,635 $4.42 Million
Q4 2020 Feb 16, 2021	BUY	$15.31 - $21.12 $5.93 Million - $8.18 Million	387,510 Added 83.94%	849,142 $17.7 Million
Q3 2020 Nov 16, 2020	BUY	$14.88 - $20.13 $3.77 Million - $5.09 Million	253,071 Added 121.34%	461,632 $7.17 Million
Q2 2020 Aug 14, 2020	SELL	$13.31 - $20.51 $7.12 Million - $11 Million	-535,118 Reduced 71.96%	208,561 $3.82 Million
Q1 2019 May 15, 2019	BUY	$20.23 - $26.29 $15 Million - $19.6 Million	743,679 New	743,679 $18.4 Million

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.